Race and sex differences in the incidence and prognostic significance of silent myocardial infarction in the Atherosclerosis Risk in Communities (ARIC) study

Circulation

Volumn 133, Issue 22, 2016, Pages 2141-2148

  Zhang, Zhu Ming ^a   Rautaharju, Pentti M ^a   Prineas, Ronald J ^a   Rodriguez, Carlos J ^a   Loehr, Laura ^b   Rosamond, Wayne D ^b   Kitzman, Dalane ^a   Couper, David ^b   Soliman, Elsayed Z ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

continental population groups; coronary heart disease; myocardial infarction; sex

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLACK PERSON; BODY MASS; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EDUCATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SEX DIFFERENCE; SILENT MYOCARDIAL INFARCTION; SMOKING; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; ANCESTRY GROUP; ATHEROSCLEROSIS; DEMOGRAPHY; ETHNOLOGY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; RISK FACTOR; SEXUAL DEVELOPMENT; TRENDS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEX CHARACTERISTICS;

EID: 84969837210     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.021177     Document Type: Article

References (40)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, De Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015 131 e29 e322. doi: 10.1161/CIR.0000000000000152
2. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction. Circulation 2007 116 2634 2653
3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction. Circulation 2012 126 2020 2035
4. Pride YB, Piccirillo BJ, Gibson CM, Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction. Am J Cardiol 2013 111 914 918. doi: 10.1016/j.amjcard.2012.11.042
5. Aguilar D, Goldhaber SZ, Gans DJ, Levey AS, Porush JG, Lewis JB, Rouleau JL, Berl T, Lewis EJ, Pfeffer MA, Collaborative Study Group Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. Am J Cardiol 2004 94 337 339. doi: 10.1016/j.amjcard.2004.04.028
6. Boland A, Gérardy J, Mossay D, Delapierre D, Seutin V, Pirlindole and dehydropirlindole protect rat cultured neuronal cells against oxidative stress-induced cell death through a mechanism unrelated to MAO-A inhibition. Br J Pharmacol 2002 135 713 720. doi: 10.1038/sj.bjp.0704519
7. Davis TM, Fortun P, Mulder J, Davis WA, Bruce DG, Fremantle Diabetes Study Silent myocardial infarction and its prognosis in a community-based cohort of type 2 diabetic patients: the Fremantle Diabetes Study. Diabetologia 2004 47 395 399. doi: 10.1007/s00125-004-1344-4
8. De Torbal A, Boersma E, Kors JA, van Herpen G, Deckers JW, van der Kuip DA, Stricker BH, Hofman A, Witteman JC, Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 2006 27 729 736. doi: 10.1093/eurheartj/ehi707
9. Grimm RH Jr, Tillinghast S, Daniels K, Neaton JD, Mascioli S, Crow R, Pritzker M, Prineas RJ, Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1987 75 pt 2 II6 II8
10. Jónsdóttir LS, Sigfusson N, Sigvaldason H, Thorgeirsson G, Incidence and prevalence of recognised and unrecognised myocardial infarction in women: the Reykjavik Study. Eur Heart J 1998 19 1011 1018
11. Kannel WB, Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. Circulation 1987 75 II4 II5
12. Kannel WB, Abbott RD, Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 1984 311 1144 1147. doi: 10.1056/NEJM198411013111802
13. Kannel WB, Cupples LA, Gagnon DR, Incidence, precursors and prognosis of unrecognized myocardial infarction. Adv Cardiol 1990 37 202 214
14. Kannel WB, McNamara PM, Feinleib M, Dawber TR, The unrecognized myocardial infarction: fourteen-year follow-up experience in the Framingham study. Geriatrics 1970 25 75 87
15. Margolis JR, Kannel WS, Feinleib M, Dawber TR, McNamara PM, Clinical features of unrecognized myocardial infarction-silent and symptomatic: eighteen year follow-up: the Framingham study. Am J Cardiol 1973 32 1 7
16. Medalie JH, Goldbourt U, Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med 1976 84 526 531
17. Nadelmann J, Frishman WH, Ooi WL, Tepper D, Greenberg S, Guzik H, Lazar EJ, Heiman M, Aronson M, Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: the Bronx Aging Study. Am J Cardiol 1990 66 533 537
18. Rosenman RH, Friedman M, Jenkins CD, Straus R, Wurm M, Kositchek R, Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. Am J Cardiol 1967 19 776 782
19. Sheifer SE, Gersh BJ, Yanez ND 3rd, Ades PA, Burke GL, Manolio TA, Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000 35 119 126
20. Shlipak MG, Elmouchi DA, Herrington DM, Lin F, Grady D, Hlatky MA, Heart and Estrogen/progestin Replacement Study Research Group The incidence of unrecognized myocardial infarction in women with coronary heart disease. Ann Intern Med 2001 134 1043 1047
21. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N, Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris: the Reykjavik Study. Ann Intern Med 1995 122 96 102
22. Stokes J 3rd, Dawber TR, The silent coronary: the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham study. Ann Intern Med 1959 50 1359 1369
23. Yano K, MacLean CJ, The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. Arch Intern Med 1989 149 1528 1532
24. Burgess DC, Hunt D, Li L, Zannino D, Williamson E, Davis TM, Laakso M, Kesäniemi YA, Zhang J, Sy RW, Lehto S, Mann S, Keech AC, Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J 2010 31 92 99. doi: 10.1093/eurheartj/ehp377
25. Kannel WB, Sorlie P, McNamara PM, Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol 1979 44 53 59
26. Crow RS, Prineas RJ, Hannan PJ, Grandits G, Blackburn H, Prognostic associations of Minnesota Code serial electrocardiographic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1997 80 138 144
27. Ammar KA, Samee S, Makwana R, Urban L, Mahoney DW, Kors JA, Redfield MM, Jacobsen S, Rodeheffer RJ, Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community population. Am J Cardiol 2005 96 1069 1075. doi: 10.1016/j.amjcard.2005.06.036
28. Kehl DW, Farzaneh-Far R, Na B, Whooley MA, Prognostic value of electrocardiographic detection of unrecognized myocardial infarction in persons with stable coronary artery disease: data from the Heart and Soul Study. Clin Res Cardiol 2011 100 359 366. doi: 10.1007/s00392-010-0255-2
29. ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989 129 687 702
30. Prineas RJ, Crow RS, Blackburn H, The Minnesota Code Manual of Electrocardiographic Findings 1982 Boston, MA John Wright PSB 203
31. Prineas RJ, Crow RS, Zhang ZM, The Minnesota Code Manual of Electrocardiographic Findings 2010 2nd ed London, UK Springer
32. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA, Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996 49 223 233
33. Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, Wagenknecht L, Ni H, Folsom AR, Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation 2012 125 1848 1857. doi: 10.1161/CIRCULATIONAHA.111.047480
34. ARIC Investigators. Manual 3: Surveillance Component Procedures Manual of Operations. Version 6.4 2015. http://www2.cscc.unc.edu/aric/surveillance-manuals. Accessed July 29, 2015
35. Frongillo E,. Evaluating statistical interactions. https://www.cscu.cornell.edu/news/statnews/stnews64.pdf. Accessed July 29, 2015
36. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Bittner VA, Lewis CE, Gamboa C, Cushman M, Howard V, Howard G, REGARDS Investigators Association of race and sex with risk of incident acute coronary heart disease events. JAMA 2012 308 1768 1774. doi: 10.1001/jama.2012.14306
37. Sheifer SE, Manolio TA, Gersh BJ, Unrecognized myocardial infarction. Ann Intern Med 2001 135 801 811
38. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998 280 605 613
39. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB, Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006 113 2733 2743. doi: 10.1161/CIRCULATIONAHA.105.570648
40. Boland LL, Folsom AR, Sorlie PD, Taylor HA, Rosamond WD, Chambless LE, Cooper LS, Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study). Am J Cardiol 2002 90 927 931